VisuMax; VISUMAX 800
Carl Zeiss Meditec, Inc. · Decision date Dec 18, 2025
What did the FDA approve?
FDA records P150040/S020 as a supplement to PMA P150040, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Dec 18, 2025.
FDA approval order statement
labeling update that includes the Post-Approval study data from the VisuMax SMILE New Enrollment Study for the VisuMax Femtosecond Laser
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Ophthalmic
- Decision date
- Dec 18, 2025
- FDA change category
- Labeling Change - PAS
Regulatory record facts
- Identifier
- P150040/S020
- Regulatory pathway
- PMA supplement
- Applicant
- Carl Zeiss Meditec, Inc.
- Product code
- OTL
- Decision code
- APPR
- Decision date
- Dec 18, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Femtosecond laser system for refractive correction.
- Applicant
- Carl Zeiss Meditec, Inc.
- Product code
- OTL
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P150040/S020 received
Application receipt date recorded by FDA.
P150040/S021 · Related supplement
Visumax; VISUMAX 800
P150040/S023 · Related supplement
VISUMAX 800 Femtosecond Laser
P150040/S020 · FDA decision
Normal 180 Day Track No User Fee
P150040/S025 · Related supplement
Visumax Femtosecond Laser
P150040/S024 · Related supplement
VISUMAX 800 Femtosecond Laser
Timeline entries are records held by MedtechLedger for P150040. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150040
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Visumax; VISUMAX 800P150040/S021 | Carl Zeiss Meditec, Inc. | PMA supplement | Aug 21, 2025 | FDA |
VISUMAX 800 Femtosecond LaserP150040/S023 | Carl Zeiss Meditec, Inc. | PMA supplement | Oct 16, 2025 | FDA |
Visumax Femtosecond LaserP150040/S025 | Carl Zeiss Meditec, Inc. | PMA supplement | May 20, 2026 | FDA |
VISUMAX 800 Femtosecond LaserP150040/S024 | Carl Zeiss Meditec, Inc. | PMA supplement | May 26, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Carl Zeiss Meditec, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 5160 Hacienda Dr., Dublin, CA, 94568
Sources and methodology
- Original FDA record: P150040/S020
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


